// App-Quantinova.ai

1476 : Effect of Treat-to-Target Tocilizumab- and Methotrexate-Based Strategies on Health-Related Quality of Life in Newly Diagnosed Rheumatoid Arthritis Patients: Results of the U-Act-Early Trial

Researchers

Presenter

  • Xavier M Teitsma

Principal Investigators

  • Johannes WG Jacobs

  • Paco MJ Welsing

  • Attila Peth-Schramm

  • Michelle EA Borm

  • Jacob M. van Laar

  • Floris PJ Lafeber

  • Johannes W.J. Bijlsma

Medical Centers

  • Pediatric Surgery, University Medical Center Utrecht, Utrecht, Netherlands

  • Pediatric Surgery, University Medical Center Utrecht, Utrecht, Netherlands

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Beneluxlaan 2a, Roche Nederland BV, Woerden, Netherlands

  • Pediatric Surgery, University Medical Center Utrecht, Utrecht, Netherlands

Locations

  • Netherlands

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved